Detalles de la búsqueda
1.
Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial.
Eur Urol
; 79(5): 595-604, 2021 05.
Artículo
Inglés
| MEDLINE | ID: mdl-33293077
2.
Robot-assisted extended pelvic lymph node dissection in prostate cancer. When and how?
Arch Esp Urol
; 72(3): 257-265, 2019 04.
Artículo
Inglés
| MEDLINE | ID: mdl-30945652
3.
Reply to Alberto Briganti, Giorgio Gandaglia, Markus Graefen, Steven Joniau, R. Jeffrey Karnes, and Francesco Montorsi's Letter to the Editor re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol 2021;79:595-604. Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer.
Eur Urol
; 79(6): e184-e185, 2021 06.
Artículo
Inglés
| MEDLINE | ID: mdl-33685836
4.
Reply to: Axel Heidenreich. Still Unanswered: The Role of Extended Pelvic Lymphadenectomy in Improving Oncological Outcomes in Prostate Cancer. Eur Urol 2021;79:605-6.
Eur Urol
; 79(5): 607-608, 2021 05.
Artículo
Inglés
| MEDLINE | ID: mdl-33608154
Resultados
1 -
4
de 4
1
Próxima >
>>